Fuan Pharmaceutical (Group) (300194.SZ) Earnings Analysis
Fuan Pharmaceutical (Group) (300194.SZ) has no confirmed upcoming earnings date. Trailing P/E 71.76.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300194.SZ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 300194.SZ. This page updates as the calendar is published.
300194.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-29 | 0.04467 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.0383 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.06 CNY | n/a | n/a | n/a |
| 2024-10-24 | 0.07155 CNY | n/a | n/a | n/a |
| 2024-08-30 | 0.07899 CNY | n/a | n/a | n/a |
300194.SZ valuation and analyst view
| Trailing P/E | 71.76 |
|---|---|
| Trailing EPS | 0.05284 CNY |
| Price / book | 1.00 |
| Dividend yield | 1.89% |
| Market cap | 4.40B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Fuan Pharmaceutical (Group) (300194.SZ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 300194.SZ. This page updates as the calendar is published.
Did 300194.SZ beat earnings last quarter?
Consensus estimate data was not available for 300194.SZ's 2025-09-29 report.
What is 300194.SZ's current P/E ratio and EPS?
300194.SZ trades at a trailing P/E of 71.76 on trailing EPS of 0.05283996951794354 CNY.
What do analysts rate 300194.SZ?
300194.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.